德龍激光(688170.SH):公司CPO光模塊生產設備相關業務在公司整體收入中佔比較小
格隆匯8月10日丨有投資者向德龍激光(688170.SH)提問,“貴公司在光模塊設備上目前有正常出貨麼?貴公司設備在光模塊製程中扮演一個什麼角色?”,公司回覆稱,公司CPO光模塊生產設備相關業務在公司整體收入中佔比較小,業務正常進行。公司主要給光通訊行業客户提供自動化裝配類解決方案、自動化測試類解決方案、激光切割、焊接類解決方案,並正在開發通訊器件的微組裝和測試聯線解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.